Search Results - "Davis, Justin W"
-
1
Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota
Published in Oncotarget (20-10-2015)“…Recent studies investigating the human microbiome have identified particular bacterial species that correlate with the presence of colorectal cancer. To…”
Get full text
Journal Article -
2
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens
Published in PloS one (31-05-2018)“…Genetic variants of inosine triphosphatase (ITPA) that confer reduced ITPase activity are associated with protection against ribavirin(RBV)-induced hemolytic…”
Get full text
Journal Article -
3
The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms
Published in Inflammatory bowel diseases (02-05-2023)“…Abstract Background Janus kinase (JAK) 1 inhibitor upadacitinib and IL-23 inhibitor risankizumab are efficacious in inflammatory bowel disease (IBD) patients…”
Get full text
Journal Article -
4
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Published in The lancet oncology (01-08-2020)“…Outcomes for children and adults with advanced soft tissue sarcoma are poor with traditional therapy. We investigated whether the addition of pazopanib to…”
Get full text
Journal Article -
5
Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab
Published in Journal of allergy and clinical immunology (01-06-2019)“…IL-23 contributes to the activation, maintenance, and proliferation of TH17 cells and plays a major role in psoriasis pathophysiology. IL-23p19 inhibition with…”
Get full text
Journal Article -
6
Association of peripheral blood DNA methylation level with Alzheimer's disease progression
Published in Clinical epigenetics (01-12-2021)“…Identifying biomarkers associated with Alzheimer's disease (AD) progression may enable patient enrichment and improve clinical trial designs. Epigenome-wide…”
Get full text
Journal Article -
7
Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease
Published in Clinical epigenetics (15-06-2020)“…Alzheimer's disease (AD) is a chronic progressive neurodegenerative disease impacting an estimated 44 million adults worldwide. The causal pathology of AD…”
Get full text
Journal Article -
8
Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study
Published in Journal of Crohn's and colitis (09-11-2018)“…We aimed to investigate the underlying mechanism of action of risankizumab, a monoclonal antibody targeting the IL-23 p19 subunit, previously reported to…”
Get full text
Journal Article -
9
Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort
Published in Journal of Alzheimer's disease (01-01-2019)“…Although shorter telomeres have been associated with Alzheimer's disease (AD), it is unclear whether longitudinal change in telomere length is associated with…”
Get more information
Journal Article -
10
Integrative analysis of DNA methylation and gene expression identifies genes associated with biological aging in Alzheimer's disease
Published in Alzheimer's & dementia : diagnosis, assessment & disease monitoring (2022)“…Introduction The acceleration of biological aging is a risk factor for Alzheimer's disease (AD). Here, we performed weighted gene co‐expression network…”
Get full text
Journal Article -
11
Comparison of exposure response relationship of atrasentan between North American and Asian populations
Published in Diabetes, obesity & metabolism (01-04-2017)“…Aims The selective endothelin (ET) A receptor antagonist atrasentan has been shown to lower albuminuria in North American and Asian patients with type 2…”
Get full text
Journal Article -
12
In vivo tropisms and kinetics of rat theilovirus infection in immunocompetent and immunodeficient rats
Published in Virus research (01-09-2011)“…► Introduce a rat model to study Theilovirus pathogenesis. ► Rat Theilovirus 1 has tropisms for the epithelial cells of the small intestine. ► Sustained high…”
Get full text
Journal Article -
13
Association of peripheral blood DNA methylation levels with Alzheimer’s disease progression
Published in Alzheimer's & dementia (01-12-2021)“…Background Identifying biomarkers associated with Alzheimer’s disease (AD) progression may enable patient enrichment and improve clinical trial designs…”
Get full text
Journal Article -
14
-
15
Pathologic response in children and adults with large unresected intermediate- or high-grade soft tissue sarcoma receiving preoperative chemoradiation with or without pazopanib (ARST1321; PAZNTIS): a multicentre, randomised, open-label, phase 2 trial
Published in The lancet oncology (20-07-2020)Get full text
Journal Article -
16
DNA METHYLATION DYNAMICS IN ALZHEIMER’S DISEASE: DEVELOPMENT OF BIOMARKERS AND NOVEL DRUG TARGETS USING ADNI EPIGENETIC DATA
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
17
P3‐120: DNA METHYLATION DYNAMICS IN ALZHEIMER'S DISEASE: DEVELOPMENT OF BIOMARKERS AND NOVEL DRUG TARGETS USING ADNI EPIGENETIC DATA
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
18
Comparison of exposure response relationship of atrasentan between N orth A merican and A sian populations
Published in Diabetes, obesity & metabolism (01-04-2017)“…Aims The selective endothelin ( ET ) A receptor antagonist atrasentan has been shown to lower albuminuria in N orth A merican and A sian patients with type 2…”
Get full text
Journal Article -
19
DNA METHYLATION DYNAMICS IN ALZHEIMER’S DISEASE DIAGNOSIS AND PROGRESSION
Published in Alzheimer's & dementia (01-07-2017)Get full text
Journal Article -
20
P3‐120: DNA METHYLATION DYNAMICS IN ALZHEIMER'S DISEASE: DEVELOPMENT OF BIOMARKERS AND NOVEL DRUG TARGETS USING ADNI EPIGENETIC DATA
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article